Truist Financial Corp reduced its position in Henry Schein, Inc. (NASDAQ:HSIC – Free Report) by 47.5% in the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 8,688 shares of the company’s stock after selling 7,849 shares during the quarter. Truist Financial Corp’s holdings in Henry Schein were worth $705,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
A number of other hedge funds have also modified their holdings of HSIC. Bank Julius Baer & Co. Ltd Zurich boosted its position in shares of Henry Schein by 67,055.8% in the second quarter. Bank Julius Baer & Co. Ltd Zurich now owns 6,737,741 shares of the company’s stock worth $546,431,000 after purchasing an additional 6,727,708 shares during the period. Perpetual Ltd bought a new position in shares of Henry Schein during the first quarter worth $347,420,000. Morgan Stanley boosted its position in shares of Henry Schein by 143.4% during the fourth quarter. Morgan Stanley now owns 2,337,890 shares of the company’s stock worth $186,727,000 after acquiring an additional 1,377,207 shares during the last quarter. Norges Bank bought a new position in shares of Henry Schein during the fourth quarter worth $109,932,000. Finally, Longview Partners Guernsey LTD boosted its position in shares of Henry Schein by 3.5% during the first quarter. Longview Partners Guernsey LTD now owns 7,263,670 shares of the company’s stock worth $592,280,000 after acquiring an additional 248,659 shares during the last quarter. 93.31% of the stock is currently owned by institutional investors.
Henry Schein Trading Up 0.7 %
Shares of HSIC opened at $63.43 on Thursday. Henry Schein, Inc. has a twelve month low of $60.01 and a twelve month high of $89.72. The company has a market cap of $8.28 billion, a P/E ratio of 18.66, a P/E/G ratio of 1.74 and a beta of 0.87. The company has a current ratio of 1.72, a quick ratio of 0.91 and a debt-to-equity ratio of 0.27. The company’s fifty day simple moving average is $71.35 and its 200-day simple moving average is $75.70.
Wall Street Analysts Forecast Growth
A number of brokerages recently weighed in on HSIC. Stifel Nicolaus dropped their target price on shares of Henry Schein from $80.00 to $70.00 and set a “hold” rating for the company in a research report on Wednesday, November 1st. JPMorgan Chase & Co. upped their target price on shares of Henry Schein from $80.00 to $83.00 and gave the stock a “neutral” rating in a research report on Wednesday, August 9th. Bank of America decreased their price target on shares of Henry Schein from $76.00 to $75.00 in a research note on Monday, August 7th. Piper Sandler decreased their price target on shares of Henry Schein from $94.00 to $84.00 and set an “overweight” rating on the stock in a research note on Thursday, October 26th. Finally, Credit Suisse Group reaffirmed an “outperform” rating and set a $96.00 price target on shares of Henry Schein in a research note on Tuesday, August 8th. One research analyst has rated the stock with a sell rating, three have issued a hold rating and four have issued a buy rating to the company’s stock. According to MarketBeat.com, the company presently has a consensus rating of “Hold” and a consensus target price of $81.13.
About Henry Schein
Henry Schein, Inc provides health care products and services to dental practitioners and laboratories, physician practices, ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.
- Five stocks we like better than Henry Schein
- Stocks with Unusual Volume: How to Find Unusual Volume Stocks in Real Time
- Investing in large cap stocks: Diving into big caps
- What Investors Must Know About Over-the-Counter (OTC) Stocks
- Why you can make Vertex Pharmaceuticals a buy on any pullback
- The Dividend Kings With Highest Yield
- Occidental Petroleum: Another bounce from the buy zone
Receive News & Ratings for Henry Schein Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein and related companies with MarketBeat.com's FREE daily email newsletter.